Channel News Asia Archives - Page 2 of 2

Early Detection

Our proprietary miRNA technology detects cancer at its earliest, most treatable stages. With minimally invasive test and accurate insights, our tests enable patients to act sooner.

GASTROClear

A pioneering blood test for the early detection of gastric (stomach) cancer.

LUNGClear

A minimally invasive blood test designed to identify lung cancer at an early stage.

Therapy Selection

We leverage advanced Next-Generation Sequencing (NGS) technology to empower patients in personalised cancer treatment selection.

APEX Tissue

A Targeted 58-Gene Profiling Test

COMPASS Tissue

A Comprehensive 1021-Gene Profiling Test

Becoming A Global Hub

November 12, 2021

MiRXES, a Singapore biotechnology startup, has appointed Dr David Capes as its senior vice president and new global head of innovation on Sept 20.

Media Coverage Category: Channel News Asia

Becoming A Global Hub